IL9 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML mice, we observed that mast cell hyperplasia was similarly regulated by IL-9, as anti-IL-9 antibody administration effectively abrogated hyperplasia in the ileum as confirmed by mast cell quantitation and gene expression of mast cell proteases.